“…Some studies that examine DAT1 mRNA levels in vitro report that the 10R-allele expresses higher levels of protein material when prompted (Fuke et al, 2001;Mill et al, 2002;VanNess et al, 2005;Kanno and Ishiura, 2012), while others report higher expression in the 9R-allele (Michelhaugh et al, 2001;Miller and Madras, 2002), and others still, find no significant differences (Greenwood and Kelsoe, 2003). However, in vivo studies with healthy subjects consistently report higher DAT densities in 9R-carriers (Jacobsen et al, 2000;Van Dyck et al, 2005;Van de Giessen et al, 2009;Costa et al, 2011;Shumay et al, 2011;Spencer et al, 2013), whereas those in psychiatric patients with schizophrenia, ADHD, or substance dependence, report higher DAT densities in 10R-homozygotes (e.g. Heinz The common denominator in subjects with schizophrenia, ADHD, and substance abuse is that these conditions are characterized by pathological dysregulations of neuronal DA levels in mesolimbic projections (Stahl, 2008).…”